Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Halozyme Therapeutics Inc (NASDAQ:HALO)

11.08
Delayed Data
As of Jan 19
 -0.19 / -1.69%
Today’s Change
6.96
Today|||52-Week Range
14.38
+12.15%
Year-to-Date
Taylor Wealth Management Partners Buys iShares Russell 2000, Eagle Materials Inc, Fir...
Jan 18 / GuruFocus News - Paid Partner Content
Why Halozyme Therapeutics, Inc Fell 40.6% in 2016
Jan 06 / MotleyFool.com - Paid Partner Content
Here's Why Halozyme Therapeutics Fell as Much as 11.1% Today
Jan 10 / MotleyFool.com - Paid Partner Content
Company News for January 06, 2017
Jan 06 / Zacks.com - Paid Partner Content
Halozyme Therapeutics (HALO) in Focus: Stock Up 6.4%
Jan 10 / Zacks.com - Paid Partner Content
Halozyme Therapeutics (HALO) Worth a Look: Stock Up 18%
Jan 06 / Zacks.com - Paid Partner Content
Can the Rally in Halozyme (HALO) Shares Continue?
Jan 09 / Zacks.com - Paid Partner Content
Halozyme (HALO) Up on Positive Phase II Data on PEGPH20
Jan 06 / Zacks.com - Paid Partner Content